News
Ostoform awarded Enterostomal Therapy products agreement with Premier, Inc.
Ostoform has been awarded a Technology Breakthrough designation for FLOWASSIST with Premier, Inc.
Read More
Ostoform Receives Innovative Technology Contract from Vizient for FLOWASSIST
Ostoform announced its FLOWASSIST product range has been awarded an Innovative Technology contract by Vizient, Inc. the largest provider-driven healthcare…
Read More
Ostoform Awarded €2.5M in Grant Funding from the European Innovation Council (EIC) Accelerator Program
20 October 2022, Ostoform is delighted to announce it has been awarded €2.5M in non-dilutive grant funding through the…
Read More
Ostoform Exhibiting at WOCNext® 2022
Ostoform is pleased to announce it will be exhibiting at this year’s WOCNext® conference, taking place in Fort Worth, Texas…
Read More
International MedTech veteran joins Ostoform board
4 April 2022, Ostoform has announced the appointment of Stephan Bonnelycke as a non-executive Director of the company. Stephan is…
Read More
Ostoform Raises €3 million in Funding Round
Ostoform is pleased to announce that capital investor, BGF, has led a €3 million equity investment round in Ostoform.
Read More
Ostoform Exhibiting at Medica 2021
Ostoform is pleased to announce its first-time attendance at Medica 2021. MEDICA, the world’s largest medical trade fair, will…
Read More
Ostoform and Partners Receive Funding of €2.67m through Disruptive Technologies Innovation Fund
Ostoform and consortium partners, Athlone Institute of Technology, Ross Polymers (Athlone), Synecco (Galway) and Avery Dennison (Longford) are very grateful…
Read More
Ostoform Announces U.S. Distribution Agreement with Medline Industries
At Ostoform, we are a small team of people working towards the common goal of solving problems experienced by those…
Read More
Ostoform Clinical Study Published in Advances in Skin & Wound Care
Ostoform Limited today announce that Advances in Skin & Wound Care has published results of a third clinical study which…
Read More